| Market Capitalization (Millions $) |
325 |
| Shares
Outstanding (Millions) |
60 |
| Employees |
533 |
| Revenues (TTM) (Millions $) |
216 |
| Net Income (TTM) (Millions $) |
-275 |
| Cash Flow (TTM) (Millions $) |
-27 |
| Capital Exp. (TTM) (Millions $) |
11 |
Business Description
Vanda Pharmaceuticals is a biopharmaceutical company that is focused on developing a range of products for the treatment of central nervous system disorders. The company is headquartered in Washington, DC, and was founded in 2002 by Mihael H. Polymeropoulos and Argeris N. Karabelas.
The company has a deep pipeline of products that includes both small molecules and biologics. Its lead product is Fanapt, which is the first and only FDA-approved drug for the treatment of schizophrenia. It is also developing a range of products for the treatment of other neurological disorders such as Huntington's disease, jet lag, and sleep disorders.
Vanda Pharmaceuticals is known for its innovative approach to drug development, using cutting-edge technology and scientific methods to create new products that have the potential to transform the lives of patients. The company's researchers draw on a range of disciplines, including genetics, neurobiology, and pharmacology, to find new targets and develop new drugs.
Over the years, Vanda Pharmaceuticals has received numerous awards and recognitions for its work. In 2010, the company was recognized as one of the fast-growing private companies in the US by Inc. Magazine. In 2013, it received the Ernst & Young Entrepreneur of the Year Award.
The company has a strong financial position, with a market capitalization of approximately $800 million as of 202 Its stock is traded on the NASDAQ exchange under the symbol VNDA.
In terms of its corporate culture, Vanda Pharmaceuticals is committed to creating a supportive and collaborative work environment. The company values diversity, and its employees come from a range of backgrounds and nationalities. It is also committed to giving back to the community, with a focus on supporting healthcare initiatives and promoting education and scientific research.
Overall, Vanda Pharmaceuticals is an important player in the biopharmaceutical industry, with a reputation for innovation, scientific excellence, and a commitment to improving the lives of patients.
Company Address: 2200 Pennsylvania Avenue NW Washington 20037 DC
Company Phone Number: 734-3400 Stock Exchange / Ticker: NASDAQ VNDA
|
0.73% 
129.73 %